Market accessOfficial

AEMPS warns topical minoxidil for hair loss can seriously harm pets, especially cats

🇪🇸 AEMPS · Thu 22 Oct 2026

Spain's medicines agency says indirect contact with treated owners can cause severe cardiovascular toxicity and death in companion animals, and urges vets and prescribers to report cases.

The Spanish Agency for Medicines and Medical Devices (AEMPS) has issued a safety alert, reference MVET 13/2026, on the risk to companion animals from human topical medicines containing minoxidil. The products are authorised for androgenetic alopecia in adults. AEMPS says they can cause serious cardiovascular toxicity and fatal outcomes in pets, particularly cats. The page gives 26 October 2026 as its publication date.

Exposure is not limited to direct ingestion. Animals can also be exposed indirectly through an owner's contaminated skin, such as the hands, or through objects that have touched the medicine, including pillows and other bedding. AEMPS lists hypotension, reflex tachycardia, pulmonary oedema, pleural effusion and congestive heart failure among the effects. Lethargy, ataxia and tremors are also described. Because some signs are non-specific, the agency says many cases may go unrecognised or never be linked to a household minoxidil product.

The agency cites retrospective analyses from poison centres, case reports and a recent literature review. It highlights data from the ASPCA Animal Poison Control Center in the US: of 211 reported exposures, dogs and cats showed clinical signs after very small amounts, such as a few drops or licks. Eight of the 62 cats that developed signs died (12.9%). Indirect exposure through treated owners was the most common circumstance in cats.

A review of the European database, which includes worldwide data, found at least eight minoxidil-related cases: four in Spain, three in Belgium and one in the US. They involved three cats and five dogs.

AEMPS advises doctors and pharmacists to warn patients using minoxidil and to recommend keeping pets away from treated skin, hands, clothing, bedding and other surfaces that may be contaminated. Anyone suspecting exposure should contact a vet at once, even if the animal shows no signs. Vets are asked to include minoxidil in the differential diagnosis, particularly for cats with cardiovascular or respiratory signs, and to look for sources of exposure. The agency states there is no specific antidote. Treatment relies on early decontamination where possible, cardiovascular and respiratory support, and management of complications, with intensive monitoring in severe cases. Suspected adverse events should be reported through NotificaVET whatever their severity.

What it means for your team

  • Pharmacovigilance teams for minoxidil products should expect more attention to animal exposure and possibly more veterinary adverse-event reports reaching marketing authorisation holders.
  • Regulatory affairs teams may wish to review patient-facing materials and counselling points for household pet exposure. The AEMPS note does not announce any label change or regulatory action.
  • Prescribers and pharmacists in Spain are asked to counsel patients on keeping pets away from treated skin, hands, clothing and bedding.
  • Veterinary reports of suspected minoxidil exposure should go through NotificaVET, regardless of severity.

Official source: AEMPS ↗

Article written by VigiEye from the official source (AEMPS). AI-assisted; check the source before acting.

More Market access All →